Consumer advocacy group Public Citizen on Tuesday filed a petition with the U.S. Food and Drug Administration seeking to require makers of Botox and several similar injections to include stronger warnings about the risk of a potentially fatal muscle-paralyzing disease. These injections, which use various versions of botulinum toxins to contract specific muscles by blocking certain nerve signals to erase wrinkles, already have a 'black box' warning in their labels about the risks of the intended effect spreading to other areas. The consumer group asked the FDA to make it clear that these adverse effects could happen even at recommended dosages.
Public Citizen seeks clearer FDA warnings against Botox seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
North Carolina Uniform Trade Secrets Act Lawsuit natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
Revance Therapeutics Stock: Not Even Daxxify Can Treat Investor Frown Lines (NASDAQ:RVNC) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Revance Therapeutics (NASDAQ:RVNC – Free Report) had its price objective lowered by Mizuho from $35.00 to $16.00 in a research report report published on Wednesday, Benzinga reports. Mizuho currently has a buy rating on the biopharmaceutical company’s stock. Other analysts have also recently issued research reports about the company. BNP Paribas upgraded Revance Therapeutics from […]